Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure

Kidney International

Volumn 50, Issue 6, 1996, Pages 1928-1935

  Vaziri, Nosratola D ^a,b   Liang, Kaihui ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPROTEIN LIPASE;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0029854433     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.515     Document Type: Article

References (33)

1. CHAN MK, VARGHESE Z, MOORHEAD JF: Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int 19:625-637, 1981
2. HAHN R, OETTE K, MONDORF H, FINKE K, SIEBERTH HG: Analysis of cardiovascular risk factors in chronic hemodialysis patients with special attention to the hyperlipoproteinemias. Atherosclerosis 48: 279-288, 1983
3. ATTMAN PO, SAMUELSON O, ALAUPOVIC P: Lipoprotein metabolism in renal failure. Am J Kidney Dis 21:573-592, 1993
4. ATTMAN PO, ALAUPOVIC P, GUSTAVSON A: Serum apolipoprotein profile of patients with chronic renal failure. Kidney Int 32:368-375, 1987
5. ALSAYED N, REBOURCET R: Abnormal concentrations of CII, CIII and E apolipoproteins among apolipoprotein B-containing, B-free, and A-I containing lipoprotein particles in hemodialysis patients. Clin Chem 37:387-393, 1991
6. NESTEL PJ, FIDGE NH, TAN MH: Increased lipoprotein-remnant formation in chronic renal failure. N Engl J Med 307:329-333, 1982
7. MORDASINI R, FREY F, FLURY W, KLOSE G, GRETEN H: Selective deficiency of hepatic triglyceride lipase in uremic patients. N Engl J Med 297:1362-1366, 1977
8. GOLDBERG A, SHERRARD DJ, BRUNZELL JD: Adipose tissue lipoprotein lipase in chronic hemodialysis: Role in plasma triglyceride metabolism. J Clin Endocrinol Metab 47:1173-1182, 1978
9. GOLDBERG AP, APPLEBAUM-BOWDEN DM, BIERMAN EL, HAZZARD WR, HAAS LB, SHERRAR DJ, BRUNZELL JD, HUTTUNEN JK, EHNHOLM C, NIKKILA EA: Increase in lipoprotein lipase during clofibrate treatment of hypertriglyceridemia in patients on hemodialysis. N Engl J Med 301:1073-1076, 1979
10. AKMAL M, KASIM SE, SOLIMAN AR, MASSRY SG: Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858, 1990
11. MURASE T, CATTRAN DC, RUBENSTEIN B, STEINER G: Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemia. Metabolism 24:1229-1286, 1975
12. CRAWFORD GA, MAHONY JF, STEWART JH: Impaired lipoprotein lipase activation by uraemic and post-transplant sera. Clin Sci 60:73-80, 1981
13. SERES DS, STRAIN GW, HASHIM SA, GOLDBERG IJ, LEVIN NW: Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol 3:1409-1415, 1993
14. CHEUNG AK, PARKER CJ, REN K, IVERIUS PH: Increased lipase inhibition in uremia: Identification of pre-β-HDL as a major inhibitor in normal and uremic plasma. Kidney Int 49:1360-1371, 1996
15. JOVEN J, VILELLA E, AHMAD S, CHEUNG MC, BRUNZELL JD: Lipoprotein heterogeneity in end-stage renal disease. Kidney Int 43:410-418, 1993
16. POLLOCK CA, WYNDHAM R, COLLETT PV, ELDER G, FIELD MJ, KALOWSKI S, LAWRENCE JR, WAGH DA, GEORGE CRP: Effects of erythropoietin therapy on the lipid profile in end-stage renal failure. Kidney Int 45:897-902, 1994
17. VAZIRI ND, ZHOU XJ, NAQVI F, SMITH J, OVEISI F, WANG ZQ, PURDY RE: Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am J Physiol (Endocrinol Metab) 271:E113-E122, 1996
18. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid-guanidium-thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
19. KIRSCHGESSNER TG, SVENSON KL, LUSIS AJ, SCHOTZ MC: The sequence of cDNA encoding lipoprotein lipase. J Biol Chem 262:8463-8466, 1987
20. IVERIUS PH, OSTLUND-LINDQVIST AM: Preparation, characterization and measurement of lipoprotein lipase. Meth Enzymol 129:691-704, 1986
21. SIMSOLO RB, ONG JM, KERN PA: Regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining. J Clin Invest 92:2124-2130, 1993
22. SHOJI T, NISHIZAWA Y, NISHITANI H, YAMAKAWA M, MORII H: Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int 41:1653-1661, 1992
23. SHAPIRO RJ: Catabolism of low-density lipoprotein is altered in experimental renal failure. Metabolism 42:162-269, 1993
24. CATTRAN DC, FENTON SS, WILSON DR, STEINER G: Defective triglyceride removal in lipemia associated with peritoneal dialysis and haemodialysis. Ann Intern Med 85:29-33, 1976
25. HORKKO S, HUTTUNEN K, KORHONEN T, KESANIEMI YA: Decreased clearance of low-density lipoprotein in patients with chronic renal failure. Kidney Int 45:561-570, 1994
26. WEINTRAUB M, BURSTEIN A, RASSIN T, LIRON M, RINGEL Y, CABILI S, BLUM M, PEER G, IANA A: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 42:1247-1252, 1992
27. ATTMAN PO, GUSTAFSON A: Lipid and carbohydrate metabolism in uraemia. Eur J Physiol 9:285-291, 1979
28. AUWERK J, LEROY P, SCHOONJANS K: Lipoprotein lipase: Recent contributions from molecular biology. Crit Rev Clin Lab Sci 29:243-268, 1992
29. SAKURAI T, OKA T, HASEGAWA H, IGAKI N, MIKI S, GOTO T: Comparison of lipids, apolipoproteins and associated enzyme activities between diabetic and nondiabetic end-stage renal disease. Nephron 61:409-414, 1992
30. CHAN MK, PERSAUD J, VARGHESE Z, MOORHEAD JF: Pathogenic role of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 25:812-818, 1984
31. ROULLET JB, LACOUR B, YVERT JP, PRAT JJ, DRUEKE T: Factors of increase in serum triclyceride-rich lipoproteins in uremic rats. Kidney Int 27:420-425, 1985
32. HEUCK CC, LIERSCH M, RITZ E, STEGMEIR K, WIRTH A, MEHLS O: Hyperlipoproteinemia in experimental chronic renal insufficiency in the rat. Kidney Int 14:142-150, 1978
33. BERGESIO F, MONZANI G, CIUTI R, SERRUTO A, BENUCCI A, FRIZZI V, SALVADORI M: Lipids and apolipoproteins change during the progression of chronic renal failure. Clin Nephrol 38:264-270, 1992